LONG-TERM CLINICAL OUTCOMES ASSOCIATED WITH SEQUENTIAL TREATMENT OF BRAF MUTANT ADVANCED MELANOMA PATIENTS

被引：0
|
作者：
Tarhini, Ahmad [1 ]
McDermott, David [2 ,3 ]
Ambavane, Apoorva [4 ]
Benedict, Agnes [4 ]
Lee, Cho-Han [5 ]
Ritchings, Corey [5 ]
Stwalley, Brian [5 ]
Regan, Meredith [2 ,6 ]
Atkins, Michael [7 ]
机构：
[1] Moffitt Comprehens Canc Ctr & Res Inst, Tampa, FL USA
[2] Harvard Med Sch, Boston, MA 02115 USA
[3] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[4] Evidera, London, England
[5] Bristol Myers Squibb, Princeton, NJ USA
[6] Dana Farber Canc Inst, Boston, MA 02115 USA
[7] Georgetown Lombardi Comprehens Canc Ctr, Washington, DC USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2020年 / 8卷
关键词：
D O I：
10.1136/jitc-2020-SITC2020.0219
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
219
引用
收藏
页码：A130 / A131
页数：2
相关论文
共 50 条
  • [31] Long-term clinical evidence of comparable efficacy and toxicity of nivolumab and pembrolizumab in advanced melanoma treatment
    Cybulska-Stopa, Bozena
    Piejko, Karolina
    Ostaszewski, Krzysztof
    Dziura, Robert
    Galus, Lukasz
    Ziolkowska, Barbara
    Kempa-Kaminska, Natasza
    Zietek, Marcin
    Bal, Wieslaw
    Kamycka, Agnieszka
    Dudzisz-Sledz, Monika
    Kubiatowski, Tomasz
    Kaminska-Winciorek, Grazyna
    Suwinski, Rafal
    Mackiewicz, Jacek
    Czarnecka, Anna Malgorzata
    Rutkowski, Piotr
    [J]. MELANOMA RESEARCH, 2023, 33 (03) : 208 - 217
  • [32] Letter: clinical outcomes after long-term entecavir or tenofovir treatment in patients with hepatitis D and advanced fibrosis
    Huang, Rui
    Wang, Jian
    Wu, Weihua
    Yan, Xiaomin
    Wu, Chao
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 50 (04) : 471 - 471
  • [33] The Long-Term Treatment Outcomes of Mucosal Melanoma of the Head and Neck: A Clinical Review of 157 Cases
    Sun, S.
    Gao, L.
    Yi, J.
    Luo, J. W.
    Xiao, J. P.
    Li, S. Y.
    Zhang, S. P.
    Huang, X. D.
    Qu, Y.
    Wang, K.
    Zhang, Y.
    Liu, Q.
    Wu, R. Y.
    Xu, G. Z.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E346 - E347
  • [34] Clinical and economic outcomes associated with sequential treatment in patients with advanced renal cell carcinoma (aRCC).
    Regan, Meredith M.
    McDermott, David F.
    Atkins, Michael B.
    Ambavane, Apoorva
    Yang, Shuo
    Rao, Sumati
    Michaelson, M. Dror
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [35] Paradoxical oncogenesis—the long-term effects of BRAF inhibition in melanoma
    Geoffrey T. Gibney
    Jane L. Messina
    Inna V. Fedorenko
    Vernon K. Sondak
    Keiran S. M. Smalley
    [J]. Nature Reviews Clinical Oncology, 2013, 10 : 390 - 399
  • [36] Our clinical experience with targeted tumor treatment in patients with BRAF-mutant metastatic melanoma
    Ocsai, H.
    Baltas, E.
    Varga, A.
    Kemeny, L.
    Olah, J.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 : 74 - 74
  • [37] Nivolumab treatment in a patient with BRAF mutant advanced melanoma and liver failure with encephalopathy
    Colak, Rumeysa
    Kapar, Caner
    Gulturk, Ilkay
    Yilmaz, Mesut
    [J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2024, 30 (03) : 589 - 593
  • [38] Safety and efficacy evaluation of encorafenib plus binimetinib for the treatment of advanced BRAF-mutant melanoma patients
    Indini, Alice
    Mandala, Mario
    [J]. EXPERT OPINION ON DRUG SAFETY, 2020, 19 (10) : 1229 - 1236
  • [39] Ruthenium Eye Plaques for Uveal Melanoma: Long-Term Clinical Outcomes
    Marwaha, G.
    Medina, C.
    Naik, M.
    Ward, M. C.
    Wilkinson, D.
    Singh, A. D.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S303 - S303
  • [40] Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma
    Wolchok, Jedd D.
    Chiarion-Sileni, Vanna
    Gonzalez, Rene
    Grob, Jean-Jacques
    Rutkowski, Piotr
    Lao, Christopher D.
    Cowey, C. Lance
    Schadendorf, Dirk
    Wagstaff, John
    Dummer, Reinhard
    Ferrucci, Pier Francesco
    Smylie, Michael
    Butler, Marcus O.
    Hill, Andrew
    Marquez-Rodas, Ivan
    Haanen, John B. A. G.
    Guidoboni, Massimo
    Maio, Michele
    Schoffski, Patrick
    Carlino, Matteo S.
    Lebbe, Celeste
    McArthur, Grant
    Ascierto, Paolo A.
    Daniels, Gregory A.
    Long, Georgina, V
    Bas, Tuba
    Ritchings, Corey
    Larkin, James
    Hodi, F. Stephen
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (02) : 127 - +
12345